BioNTech SE (BNTX) Receivables - Net (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Receivables - Net data on file, last reported at -$73.3 million in Q4 2025.

• In Q4 2025, Receivables - Net fell 117.86% year-over-year to -$73.3 million; the TTM figure through Dec 2025 stood at -$73.3 million (down 117.86% YoY), while the FY2025 annual figure was -$71.2 million, down 111.46% from the prior year.
• Receivables - Net eased to -$73.3 million in Q4 2025, from $807.6 million in the prior quarter.
• Across five years, Receivables - Net topped out at $14.2 billion in Q1 2022 and bottomed at -$73.3 million in Q4 2025.
• A 5-year average of $4.2 billion and a median of $1.3 billion in 2025 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2024 — Receivables - Net slumped 801.24% — and 2025, when it soared 11889.14%.
• Year by year, Receivables - Net stood at $14.2 billion in 2021, then slumped by 48.53% to $7.3 billion in 2022, then plunged by 68.18% to $2.3 billion in 2023, then sank by 101.45% to -$33.7 million in 2024, then plunged by 117.86% to -$73.3 million in 2025.
• The last three Receivables - Net figures came in at -$73.3 million (Q4 2025), $807.6 million (Q3 2025), and $1.5 billion (Q2 2025), per Business Quant data.

Peer Comparison